Monday, 18 Mar 2019

You are here

Dr. Deodhar: tofacitinib, secukinumab and the treatment of ankylosing spondylitis

Dr. Atul Deodhar, a rheumatologist at Oregon Health & Science University in Portland, Oregon, discusses two late-breaking abstracts (5L and 6L) regarding the treatment of ankylosing spondylitis.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

Drs. Suleman Bhana, Paul Sufka and...

23 Oct 2018

The RheumNow Week in Review – 2 June...

02 Jun 2017

The RheumNow Week in Review - 19...

19 Jan 2018

Jack Cush, MD: Safety Perspective on...

13 Nov 2015

The RheumNow Week in Review – 24...

24 Feb 2017

RheumNow Week in Review – 19 August 2016

19 Aug 2016

Dr. Rachel T. Huston: Dilemmas in...

03 Jan 2017

Dr. Shubha Kollampare: Granulomatosis...

09 Feb 2018

RheumNow Podcast – You Owe Me a DEXA (...

15 Mar 2019

Dr. Naomi Schlesinger - Complete...

15 Jun 2017

Dr. Sam Whittle: Five Factors in Gout

22 Oct 2018

RWCS 2017: Dr. Cush Talks with Seth...

20 Feb 2017